Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22689310 | 0.81 | — | — | |
| SCHEMBL9913147 | 0.81 | DUT (0.42) | DUT | |
| SCHEMBL6704070 | 0.79 | — | — | |
| SCHEMBL4487307 | 0.79 | — | — | |
| SCHEMBL5604846 | 0.79 | — | — | |
| SCHEMBL4487319 | 0.79 | — | — | |
| SCHEMBL821115 | 0.79 | — | — | |
| SCHEMBL9628880 | 0.79 | — | — | |
| SCHEMBL16726889 | 0.79 | DUT (0.41) | DUT | |
| SCHEMBL29377049 | 0.79 | DUT (0.41) | DUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2177 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240190870-A1 | FGFR3 INHIBITOR COMPOUNDS | LOXO ONCOLOGY, INC. | 2024-06-13 | — | — | US | claimed |
| CN-110878108-B | Synthetic method of prazazolmitrin | 山东安信制药有限公司 | 2022-11-11 | — | — | CN | claimed |
| CN-108948107-B | Preparation method of prazolmitrin antibiotic | 山东大学 | 2020-05-05 | — | — | CN | claimed |
| CN-110878108-A | Synthetic method of prazazolmitrin | 齐鲁天和惠世制药有限公司 | 2020-03-13 | — | — | CN | claimed |
| CN-122079983-A | FGFR3 inhibitor compounds | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122079985-A | FGFR3 inhibitor compounds | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122079984-A | FGFR3 inhibitor compounds | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260138956-A1 | NOVEL COMPOUNDS AND USES THEREOF | RECURSION PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4003988-B1 | 3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS | SERVIER LAB (FR) | 2026-05-20 | — | — | EP | disclosed |
| CN-122036731-A | CB1 receptor inverse agonist compound, pharmaceutical composition, preparation method and application thereof | 北京康辰药业股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260132132-A1 | 3A,4,5,6-TETRAHYDRO-1 H-PYRAZOLO[3,4-C]PYRIDIN-7(7AH)-ONE DERIVATIVES AS FACTOR XIIA INHIBITORS | KALVISTA PHARMACEUTICALS LTD (GB) | 2026-05-14 | — | — | US | disclosed |
| EP-4739670-A1 | MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. Hoffmann-La Roche AG (CH) | 2026-05-13 | — | — | EP | disclosed |
| WO-1995006048-A1 | (3-PYRIDYL)TETRAFURAN-2-YL SUBSTITUTED CARBOXYLIC ACIDS | CIBA-GEIGY AG (CH) | 1995-03-02 | — | — | WO | disclosed |
| US-5385897-A | 3-(3-quaternary ammonium prop-1-enyl), 7-((2-(aminothiazol-4-yl), 2-(alkoxyimino)acetamido)-3-isocephems; penicillin-resistant staphylococcus | ROUSSEL-UCLAF (FR) | 1995-01-31 | — | — | US | disclosed |
| US-5371096-A | (3-pyridyl)tetrafuran-2-yl substituted carboxylic acids | CIBA-GEIGY CORPORATION (US) | 1994-12-06 | — | — | US | disclosed |
| US-5151417-A | Antibiotics and bactericides | EISAI CO., LTD. (JP) | 1992-09-29 | — | — | US | disclosed |
| CN-1048706-A | 3-substituted vinyl cephalosporin derivatives and preparation method thereof | EISAI CO LTD (JP) | 1991-01-23 | — | — | CN | disclosed |
| EP-0408034-A1 | 3-Substituted vinyl cephalosporin derivatives | Eisai Co., Ltd. (JP) | 1991-01-16 | — | — | EP | disclosed |
| US-4908359-A | Pharmaceuticals | Uclaf, Roussel (FR) | 1990-03-13 | — | — | US | disclosed |
| US-4383946-A | Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals | MERCK & CO., INC. (US) | 1983-05-17 | — | — | US | disclosed |